Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Stocks - Wall Street Hits New Records at Open on Virus Hopes

Published 02/12/2020, 10:03 AM
Updated 02/12/2020, 10:11 AM
© Reuters.

By Geoffrey Smith

Investing.com -- Wall Street raced to new all-time highs at the opening on Wednesday, driven by growing hopes that the coronavirus, now known as Covid-19, could soon peak.

However, China changed its methodology for counting new cases last week, and no longer includes those patients who test positive without showing symptoms. Given that the virus’ incubation period can last up to 24 days – also according to official Chinese data – that creates a clear risk of under-reporting. The economic impacts of the virus continue to become more visible, with big downward revisions to global oil demand and the increasing use of force majeure clauses by Chinese companies to get out of contractual obligations to buy inputs or deliver finished products.

By 10:05 AM ET (1505 GMT), the Dow Jones Industrial Average had risen 199 points, or 0.7%, while the S&P 500 had risen 0.4%. Both touched new record highs in the opening minutes of trading after China’s authorities published figures showing a sharp fall in new cases of Covid-19 for the second day in a row. The Nasdaq Composite was up 0.3%.

Buying was again concentrated in mega-cap stock such as Apple (NASDAQ:AAPL) and Amazon (NASDAQ:AMZN), despite a lack of newsflow out of either company.

Among those companies that did generate news on Wednesday, Shopify (NYSE:SHOP) rose 13.8% to a new all-time high after blowout numbers for its fourth quarter, and Molson Coors (NYSE:TAP) rose 5.1%, also helped by solid results (although nowhere near as solid as Heineken's (OTC:HEINY): the Dutch brewer’s ADRs rose 5.9% after its quarterly report.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Elsewhere, the shorts betting against Bed Bath & Beyond's (NASDAQ:BBBY) turnaround were vindicated after the company’s same-store sales fell short of expectations in December and January. CEO Mark Tritton blamed product availability and weaker-than-expected store visits. BB&B stock fell 25%, reversing all the gains since October.

CVS Health (NYSE:CVS) stock ground out another 1.2% increase after reporting above-forecast earnings for the fourth quarter, which were again supported by the contribution of Aetna, the insurer that it bought late in 2018.

Elsewhere, oil and gas stocks were lifted by a 2.9% rebound in U.S. crude futures, after the Organization of Petroleum Exporting Countries cut its estimate for world oil demand this year by ‘only’ 230,000 barrels a day. The U.S. government had on Tuesday estimated demand destruction of 300,000 bpd. Exxon Mobil (NYSE:XOM) rose 1.4%, while Chevron (NYSE:CVX) rose 0.9% and Devon Energy (NYSE:DVN) rose 4.3%.

The dollar index, which tracks the greenback against a basket of six developed-market currencies, found a bid again, rising 0.1% to 98.72 as the euro struggled to defend the $1.0900 level.

Latest comments

The virus cure seems to be wholesale spraying. Then people die of the fumigation instead of the virus. Problem solved Mr Xi.
Changing the numbers of infected people to sound lower... ok
Virus hopes? 😂😂😂😂😂😂Everything in China is closed until 2nd of March and nobody on the streets. The economy will crater
Scratch “trade” and insert “virus”. What are “virus hopes” anyway? Lol.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.